{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-007423","form_type":"8-K","ticker":"ANVS","cik":"0001477845","company_name":"Annovis Bio, Inc.","filed_at":"2026-01-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.164428+00:00","generated_at":"2026-05-16T06:58:00.854250+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Annovis Bio holds webinar Jan 28, 2026; no clinical or financial data furnished","bullets":["Company conducted a webinar with CEO Maria Maccecchini; no new results or data disclosed in filing.","Exhibit 99 contains only a title slide and standard forward-looking statement, no financial or clinical details.","No guidance, trial updates, or material business developments were provided in the 8-K exhibit.","Filing is procedural Regulation FD disclosure for the webinar event itself, not a substantive update."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-007423","json":"https://secwatch.observer/filing/0001104659-26-007423.json","markdown":"https://secwatch.observer/filing/0001104659-26-007423.md","text":"https://secwatch.observer/filing/0001104659-26-007423.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477845/000110465926007423/0001104659-26-007423-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477845/000110465926007423/tm264292d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T06:58:00.854250+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}